Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma
出版年份 2017 全文链接
标题
Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma
作者
关键词
Immunotherapy, GBM, ADC, MRI, Pseudoprogression
出版物
NEURORADIOLOGY
Volume 59, Issue 2, Pages 135-145
出版商
Springer Nature
发表日期
2017-01-09
DOI
10.1007/s00234-016-1769-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Diffusion and Perfusion MRI to Differentiate Treatment-Related Changes Including Pseudoprogression from Recurrent Tumors in High-Grade Gliomas with Histopathologic Evidence
- (2015) A.J. Prager et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma
- (2015) Andrew Elson et al. JOURNAL OF NEURO-ONCOLOGY
- Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
- (2015) Hideho Okada et al. LANCET ONCOLOGY
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
- (2015) D. A. Reardon et al. Cancer Immunology Research
- A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas
- (2014) A. Hilario et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors
- (2014) D. A. Wainwright et al. CLINICAL CANCER RESEARCH
- Impact of imaging measurements on response assessment in glioblastoma clinical trials
- (2014) D. A. Reardon et al. NEURO-ONCOLOGY
- Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma
- (2014) Peter S. LaViolette et al. NEURO-ONCOLOGY
- Diffusion Imaging for Tumor Grading of Supratentorial Brain Tumors in the First Year of Life
- (2013) S. F. Kralik et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Pseudoprogression after glioma therapy: a comprehensive review
- (2013) Tim J Kruser et al. Expert Review of Neurotherapeutics
- Recurrent high-grade glioma treated with bevacizumab: prognostic value of MGMT methylation, EGFR status and pretreatment MRI in determining response and survival
- (2013) Christina Chen et al. JOURNAL OF NEURO-ONCOLOGY
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Radiation Therapy and Concomitant Temozolomide: Comparison Study of Standard and High-b-Value Diffusion-weighted Imaging
- (2013) Hee Ho Chu et al. RADIOLOGY
- Recurrent Glioblastoma Treated with Bevacizumab: Contrast-enhanced T1-weighted Subtraction Maps Improve Tumor Delineation and Aid Prediction of Survival in a Multicenter Clinical Trial
- (2013) Benjamin M. Ellingson et al. RADIOLOGY
- Persistent Diffusion-Restricted Lesions in Bevacizumab-Treated Malignant Gliomas Are Associated with Improved Survival Compared with Matched Controls
- (2012) S. Mong et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI
- (2012) M. J. Wieduwilt et al. CLINICAL CANCER RESEARCH
- Isolated Diffusion Restriction Precedes the Development of Enhancing Tumor in a Subset of Patients with Glioblastoma
- (2011) A. Gupta et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma
- (2011) L.C. Hygino da Cruz et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Mechanisms of immunomodulation in human glioblastoma
- (2011) Tony Avril et al. Immunotherapy
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- MR perfusion and diffusion imaging in the follow-up of recurrent glioblastoma treated with dendritic cell immunotherapy: a pilot study
- (2010) Matej Vrabec et al. NEURORADIOLOGY
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Glioblastoma treated with postoperative radio-chemotherapy: Prognostic value of apparent diffusion coefficient at MR imaging
- (2009) Fumiyuki Yamasaki et al. EUROPEAN JOURNAL OF RADIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now